The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Mylotarg-Global Market Insights and Sales Trends 2024
Synopsis
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010.
The global Mylotarg market size is expected to reach US$ 179.5 million by 2029, growing at a CAGR of -2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Mylotarg in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Mylotarg market. 5mg/Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 4.5mg/Vial segment is estimated at % CAGR for the next seven-year period.
Gemtuzumab Ozogamicin is an antibody-drug conjugate used to treat certain types of acute myeloid leukemia (AML). Its efficacy in targeting CD33-expressing AML cells and inducing remission has driven market growth. The limited treatment options for CD33-positive AML contribute to its niche status. However, challenges include potential side effects and the need for careful patient selection. The market competition is relatively small, as Gemtuzumab Ozogamicin remains a targeted therapy for a specific AML subgroup. Despite challenges, the Gemtuzumab Ozogamicin market offers potential for growth as healthcare providers seek effective treatments for patients with CD33-positive AML. Continued research and clinical advancements can further drive market expansion.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mylotarg, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mylotarg market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mylotarg market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mylotarg sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mylotarg covered in this report include Pfizer. etc.
The global Mylotarg market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Global Mylotarg market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mylotarg market, Segment by Type:
5mg/Vial
4.5mg/Vial
Global Mylotarg market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Mylotarg manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Mylotarg in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010.
The global Mylotarg market size is expected to reach US$ 179.5 million by 2029, growing at a CAGR of -2.5% from 2023 to 2029. The market is mainly driven by the significant applications of Mylotarg in various end use industries. The expanding demands from the Hospital and Pharmacy, are propelling Mylotarg market. 5mg/Vial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 4.5mg/Vial segment is estimated at % CAGR for the next seven-year period.
Gemtuzumab Ozogamicin is an antibody-drug conjugate used to treat certain types of acute myeloid leukemia (AML). Its efficacy in targeting CD33-expressing AML cells and inducing remission has driven market growth. The limited treatment options for CD33-positive AML contribute to its niche status. However, challenges include potential side effects and the need for careful patient selection. The market competition is relatively small, as Gemtuzumab Ozogamicin remains a targeted therapy for a specific AML subgroup. Despite challenges, the Gemtuzumab Ozogamicin market offers potential for growth as healthcare providers seek effective treatments for patients with CD33-positive AML. Continued research and clinical advancements can further drive market expansion.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mylotarg, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mylotarg market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mylotarg market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mylotarg sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mylotarg covered in this report include Pfizer. etc.
The global Mylotarg market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Global Mylotarg market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mylotarg market, Segment by Type:
5mg/Vial
4.5mg/Vial
Global Mylotarg market, by Application
Hospital
Pharmacy
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Mylotarg manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Mylotarg in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Mylotarg Market Overview
1.1 Mylotarg Product Overview
1.2 Mylotarg Market Segment by Type
1.2.1 5mg/Vial
1.2.2 4.5mg/Vial
1.3 Global Mylotarg Market Size by Type
1.3.1 Global Mylotarg Market Size Overview by Type (2018-2029)
1.3.2 Global Mylotarg Historic Market Size Review by Type (2018-2023)
1.3.3 Global Mylotarg Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Mylotarg Sales Breakdown by Type (2018-2023)
1.4.2 Europe Mylotarg Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Mylotarg Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Mylotarg Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Mylotarg Sales Breakdown by Type (2018-2023)
2 Global Mylotarg Market Competition by Company
2.1 Global Top Players by Mylotarg Sales (2018-2023)
2.2 Global Top Players by Mylotarg Revenue (2018-2023)
2.3 Global Top Players by Mylotarg Price (2018-2023)
2.4 Global Top Manufacturers Mylotarg Manufacturing Base Distribution, Sales Area, Product Type
2.5 Mylotarg Market Competitive Situation and Trends
2.5.1 Mylotarg Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Mylotarg Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mylotarg as of 2022)
2.7 Date of Key Manufacturers Enter into Mylotarg Market
2.8 Key Manufacturers Mylotarg Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Mylotarg Status and Outlook by Region
3.1 Global Mylotarg Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Mylotarg Historic Market Size by Region
3.2.1 Global Mylotarg Sales in Volume by Region (2018-2023)
3.2.2 Global Mylotarg Sales in Value by Region (2018-2023)
3.2.3 Global Mylotarg Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Mylotarg Forecasted Market Size by Region
3.3.1 Global Mylotarg Sales in Volume by Region (2024-2029)
3.3.2 Global Mylotarg Sales in Value by Region (2024-2029)
3.3.3 Global Mylotarg Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Mylotarg by Application
4.1 Mylotarg Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.2 Global Mylotarg Market Size by Application
4.2.1 Global Mylotarg Market Size Overview by Application (2018-2029)
4.2.2 Global Mylotarg Historic Market Size Review by Application (2018-2023)
4.2.3 Global Mylotarg Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Mylotarg Sales Breakdown by Application (2018-2023)
4.3.2 Europe Mylotarg Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Mylotarg Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Mylotarg Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Mylotarg Sales Breakdown by Application (2018-2023)
5 North America Mylotarg by Country
5.1 North America Mylotarg Historic Market Size by Country
5.1.1 North America Mylotarg Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Mylotarg Sales in Volume by Country (2018-2023)
5.1.3 North America Mylotarg Sales in Value by Country (2018-2023)
5.2 North America Mylotarg Forecasted Market Size by Country
5.2.1 North America Mylotarg Sales in Volume by Country (2024-2029)
5.2.2 North America Mylotarg Sales in Value by Country (2024-2029)
6 Europe Mylotarg by Country
6.1 Europe Mylotarg Historic Market Size by Country
6.1.1 Europe Mylotarg Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Mylotarg Sales in Volume by Country (2018-2023)
6.1.3 Europe Mylotarg Sales in Value by Country (2018-2023)
6.2 Europe Mylotarg Forecasted Market Size by Country
6.2.1 Europe Mylotarg Sales in Volume by Country (2024-2029)
6.2.2 Europe Mylotarg Sales in Value by Country (2024-2029)
7 Asia-Pacific Mylotarg by Region
7.1 Asia-Pacific Mylotarg Historic Market Size by Region
7.1.1 Asia-Pacific Mylotarg Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Mylotarg Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Mylotarg Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Mylotarg Forecasted Market Size by Region
7.2.1 Asia-Pacific Mylotarg Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Mylotarg Sales in Value by Region (2024-2029)
8 Latin America Mylotarg by Country
8.1 Latin America Mylotarg Historic Market Size by Country
8.1.1 Latin America Mylotarg Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Mylotarg Sales in Volume by Country (2018-2023)
8.1.3 Latin America Mylotarg Sales in Value by Country (2018-2023)
8.2 Latin America Mylotarg Forecasted Market Size by Country
8.2.1 Latin America Mylotarg Sales in Volume by Country (2024-2029)
8.2.2 Latin America Mylotarg Sales in Value by Country (2024-2029)
9 Middle East and Africa Mylotarg by Country
9.1 Middle East and Africa Mylotarg Historic Market Size by Country
9.1.1 Middle East and Africa Mylotarg Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Mylotarg Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Mylotarg Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Mylotarg Forecasted Market Size by Country
9.2.1 Middle East and Africa Mylotarg Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Mylotarg Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Mylotarg Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Mylotarg Products Offered
10.1.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Mylotarg Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Mylotarg Industrial Chain Analysis
11.4 Mylotarg Market Dynamics
11.4.1 Mylotarg Industry Trends
11.4.2 Mylotarg Market Drivers
11.4.3 Mylotarg Market Challenges
11.4.4 Mylotarg Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Mylotarg Distributors
12.3 Mylotarg Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
